We recently showed that IBD patients expressed higher levels of OGR1 mRNA in the mucosa than healthy control subjects18,19 and moreover, the deletion of OGR1 or GPR4 protects from intestinal inflammation in experimental colitis18,20,22. This evidence concerns the gene GPR68 and inflammatory bowel disease.